These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8974080)

  • 1. Glycogen synthase kinase 3 phosphorylation of different residues in the presence of different factors: analysis on tau protein.
    Moreno FJ; Muñoz-Montaño JR; Avila J
    Mol Cell Biochem; 1996 Dec; 165(1):47-54. PubMed ID: 8974080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of GSK-3-catalyzed phosphorylation of microtubule-associated protein tau by non-proline-dependent protein kinases.
    Singh TJ; Zaidi T; Grundke-Iqbal I; Iqbal K
    FEBS Lett; 1995 Jan; 358(1):4-8. PubMed ID: 7821426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
    Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S
    Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated seryl and threonyl, but not tyrosyl, residues are efficient specificity determinants for GSK-3beta and Shaggy.
    Williams DD; Marin O; Pinna LA; Proud CG
    FEBS Lett; 1999 Apr; 448(1):86-90. PubMed ID: 10217415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation.
    Zheng-Fischhöfer Q; Biernat J; Mandelkow EM; Illenberger S; Godemann R; Mandelkow E
    Eur J Biochem; 1998 Mar; 252(3):542-52. PubMed ID: 9546672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.
    Bax B; Carter PS; Lewis C; Guy AR; Bridges A; Tanner R; Pettman G; Mannix C; Culbert AA; Brown MJ; Smith DG; Reith AD
    Structure; 2001 Dec; 9(12):1143-52. PubMed ID: 11738041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.
    Takashima A; Honda T; Yasutake K; Michel G; Murayama O; Murayama M; Ishiguro K; Yamaguchi H
    Neurosci Res; 1998 Aug; 31(4):317-23. PubMed ID: 9809590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions of the C-terminal domain of CTP: phosphocholine cytidylyltransferase. Effects of C-terminal deletions on enzyme activity, intracellular localization and phosphorylation potential.
    Cornell RB; Kalmar GB; Kay RJ; Johnson MA; Sanghera JS; Pelech SL
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):699-708. PubMed ID: 7654214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain.
    Bennecib M; Gong CX; Grundke-Iqbal I; Iqbal K
    FEBS Lett; 2000 Nov; 485(1):87-93. PubMed ID: 11086171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase 3 phosphorylates recombinant human tau protein at serine-262 in the presence of heparin (or tubulin).
    Moreno FJ; Medina M; Pérez M; Montejo de Garcini E; Avila J
    FEBS Lett; 1995 Sep; 372(1):65-8. PubMed ID: 7556645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sites of phosphorylation in tau and factors affecting their regulation.
    Anderton BH; Betts J; Blackstock WP; Brion JP; Chapman S; Connell J; Dayanandan R; Gallo JM; Gibb G; Hanger DP; Hutton M; Kardalinou E; Leroy K; Lovestone S; Mack T; Reynolds CH; Van Slegtenhorst M
    Biochem Soc Symp; 2001; (67):73-80. PubMed ID: 11447841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.
    Woods YL; Cohen P; Becker W; Jakes R; Goedert M; Wang X; Proud CG
    Biochem J; 2001 May; 355(Pt 3):609-15. PubMed ID: 11311121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.
    Sengupta A; Kabat J; Novak M; Wu Q; Grundke-Iqbal I; Iqbal K
    Arch Biochem Biophys; 1998 Sep; 357(2):299-309. PubMed ID: 9735171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
    Reynolds CH; Betts JC; Blackstock WP; Nebreda AR; Anderton BH
    J Neurochem; 2000 Apr; 74(4):1587-95. PubMed ID: 10737616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau protein kinase I/GSK-3 beta/kinase FA in heparin phosphorylates tau on Ser199, Thr231, Ser235, Ser262, Ser369, and Ser400 sites phosphorylated in Alzheimer disease brain.
    Song JS; Yang SD
    J Protein Chem; 1995 Feb; 14(2):95-105. PubMed ID: 7786411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5.
    Sengupta A; Wu Q; Grundke-Iqbal I; Iqbal K; Singh TJ
    Mol Cell Biochem; 1997 Feb; 167(1-2):99-105. PubMed ID: 9059986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.
    Gold MR; Scheid MP; Santos L; Dang-Lawson M; Roth RA; Matsuuchi L; Duronio V; Krebs DL
    J Immunol; 1999 Aug; 163(4):1894-905. PubMed ID: 10438924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual effects of PKNalpha and protein kinase C on phosphorylation of tau protein by glycogen synthase kinase-3beta.
    Isagawa T; Mukai H; Oishi K; Taniguchi T; Hasegawa H; Kawamata T; Tanaka C; Ono Y
    Biochem Biophys Res Commun; 2000 Jun; 273(1):209-12. PubMed ID: 10873588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
    Leclerc S; Garnier M; Hoessel R; Marko D; Bibb JA; Snyder GL; Greengard P; Biernat J; Wu YZ; Mandelkow EM; Eisenbrand G; Meijer L
    J Biol Chem; 2001 Jan; 276(1):251-60. PubMed ID: 11013232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoform differences in substrate recognition by glycogen synthase kinases 3 alpha and 3 beta in the phosphorylation of phosphatase inhibitor 2.
    Wang QM; Park IK; Fiol CJ; Roach PJ; DePaoli-Roach AA
    Biochemistry; 1994 Jan; 33(1):143-7. PubMed ID: 8286331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.